These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6930767)

  • 1. [Summary of the clinical papers on sulfinpyrazone (Anturan) under discussion with a preview of the current study program].
    Fontanilles F
    Wien Med Wochenschr Suppl; 1980; 61():23-4. PubMed ID: 6930767
    [No Abstract]   [Full Text] [Related]  

  • 2. The current status of platelet suppressive drugs in the treatment of thrombosis.
    Hirsh J; Gent M; Genton E
    Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug therapy: antiplatelet therapy (second of two parts).
    Weiss HJ
    N Engl J Med; 1978 Jun; 298(25):1403-6. PubMed ID: 349388
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets.
    Fabris F; Casonato A; Randi ML; Schivazappa L; Schiavinato L; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):594-601. PubMed ID: 6196274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs in the treatment of thrombo-embolic disease--part I.
    Bouchier-Hayes D
    Ir Med J; 1983 Feb; 76(2):101-5, 107. PubMed ID: 6601642
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: The effect of sulphinpyrazone (Anturan) on immunologically derived thrombocytopenia and on platelet survival.
    White AM; Butler KD
    Thromb Diath Haemorrh; 1975 Nov; 34(2):553-4. PubMed ID: 128152
    [No Abstract]   [Full Text] [Related]  

  • 7. A controlled study of the effect of sulfinpyrazone on platelet survival and on platelet-bound 14C-serotonin release in patients with previous myocardial infarction.
    Cortellaro M; Boschetti C; Fassio G; Basagni M; Polli EE
    Acta Haematol; 1979; 61(2):68-74. PubMed ID: 217218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet survival time and thromboembolism in patients with mitral valve prolapse.
    Steele P; Weily H; Rainwater J; Vogel R
    Circulation; 1979 Jul; 60(1):43-5. PubMed ID: 445732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: The effect of a platelet inhibiting drug (sulfinpyrazone) in the therapy of patients with transient ischemic attacks (Tia's) and minor strokes.
    Robertson JT; Dugdale M; Salky N; Robinson H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):598. PubMed ID: 1105880
    [No Abstract]   [Full Text] [Related]  

  • 10. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
    Friedman LM
    Circulation; 1980 Dec; 62(6 Pt 2):V88-9. PubMed ID: 7002355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets.
    Hirsh J
    Can Med Assoc J; 1973 Feb; 108(4):416 passim. PubMed ID: 4687370
    [No Abstract]   [Full Text] [Related]  

  • 12. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiplatelet therapy.
    Turpie AG
    Clin Haematol; 1981 Jun; 10(2):497-520. PubMed ID: 7032786
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of sulfinpyrazone on platelet survival time in patients with transient cerebral ischemic attacks.
    Steele P; Carroll J; Overfield D; Genton E
    Stroke; 1977; 8(3):396-8. PubMed ID: 871029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Canadian cooperative study of platelet suppressant therapy in threatened stroke.
    Gent M
    Thromb Haemost; 1979 Feb; 41(1):163-70. PubMed ID: 483230
    [No Abstract]   [Full Text] [Related]  

  • 16. Arteriovenous-shunt thrombosis. Prevention by sulfinpyrazone.
    Kaegi A; Pineo GF; Shimizu A; Trivedi H; Hirsh J; Gent M
    N Engl J Med; 1974 Feb; 290(6):304-6. PubMed ID: 4588285
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Comparative effects of platelet suppressant drugs on platelet survival time.
    Genton E; Ellis J; Steele P
    Thromb Diath Haemorrh; 1975 Nov; 34(2):552. PubMed ID: 1198422
    [No Abstract]   [Full Text] [Related]  

  • 18. [The pharmacology of sulfinpyrazone (Anturan)].
    Rüegg M
    Wien Med Wochenschr Suppl; 1980; 61():3-8. PubMed ID: 6930768
    [No Abstract]   [Full Text] [Related]  

  • 19. The Canadian trial of aspirin and sulfinpyrazone in threatened stroke.
    N Engl J Med; 1978 Oct; 299(17):953-5. PubMed ID: 357975
    [No Abstract]   [Full Text] [Related]  

  • 20. Favorable effect of sulfinpyrazone on thromboembolism in patients with rheumatic heart disease.
    Steele P; Rainwater J
    Circulation; 1980 Sep; 62(3):462-5. PubMed ID: 7398003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.